360° SearchNetwork Hot Spots Trends Time Series

Metastases

Type: Keyphrase

Name: Metastases

First reported 15 hours ago - Updated 15 hours ago - 1 reports

Biopsy-proven brain metastases from prostate cancer: A series of four cases with review of the literature - Abstract

AIMS: Prostate cancer is very common and is the second most common cause of cancer death in males in Australia; however, brain metastases are exceedingly rare.To read more, a FREE Urotoday registration is required. Click here to register or login abo ... [Published UroToday - 15 hours ago]

Entities: Metastases, Prostate Cancer, Cancer

First reported Jun 19 2013 - Updated Jun 19 2013 - 1 reports

Some Squamous Cell Skin Cancers Are Deadly

Categories: General Skin Cancer, News, Skin Cancer Cutaneous squamous cell carcinoma is usually easily treated with surgery; however, a subsection of patients with specific disease risk factors are more likely to develop metastases and die from the disease, ... [Published CancerConnect.com - Jun 19 2013]

Entities: squamous cell carcinoma, Tumor, Skin Cancer, squamous cell

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Prostate Enzyme Enables Detection Of Metastases During Molecular Imaging

New York, N.Y, June 17,2013 - No matter where they have hidden, metastatic prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme.Harnessing this enzyme could mean the ... [Published Health Imaging Hub - Jun 17 2013]

Entities: Prostate Cancer, Prostate, Metastases, Enzyme

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Utility of semiquantitative parameters to differentiate benign and malignant focal hepatic lesions

Abstract: Objective: Any distinction and the usefulness of semiquantitative parameters derived from dynamic-contrast-enhanced (DCE) MRI obtained with extracellular gadolinium contrast agent in hemangiomas, hepatocellular carcinomas (HCC) and metastases ... [Published Clinical Imaging - Jun 17 2013]

Entities: Metastases, hepatic, malignant, benign

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine ...

A promising cancer vaccine involves the fusion of tumor cells with dendritic cells (DCs). As such, a broad spectrum of both known and unidentified tumor antigens is presented to the immune system in the context of the potent immunostimulatory capacity ... [Published 7thSpace - Jun 17 2013]

Entities: Murine, Vaccine, Monoclonal Antibodies, Tumor

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Groundbreaking Research in Radiation Oncology by Good Samaritan Hospital Physician

In a study published in the journal Targeted Oncology, Good Samaritan Hospital Medical Centerâs Chairman of the Department of Radiation Oncology Johnny Kao, MD, and his team reported that aggressive radiation combined with chemotherapy can extend life ... [Published Hospital Newspaper - Jun 17 2013]

Entities: Radiation, Oncology, Cancer

First reported Jun 15 2013 - Updated Jun 15 2013 - 1 reports

A life that could be saved after all

This is why I became a doctor.I suspect even grown-up doctors feel this way. Most days at work are routine, sometimes even tedious. Relentless is another adjective I have heard used to describe our day-to-day hospital life. But from time to time something ... [Published British Medical Association - Jun 15 2013]

Entities: biopsy, Tumor, Metastases, Metastatic, gastrointestinal

First reported Jun 13 2013 - Updated Jun 14 2013 - 2 reports

Prostate Enzyme Abel to Detect Metastases during Molecular Imaging

Despite their crafty elusiveness, prostate cancer cells still exhibit much of the same signals as ordinary prostate cells do; in some instances even more so, as the PSMA enzyme alludes. Honing such an enzyme could lead to all kinds of possibilities, regarding ... [Published Health Imaging Hub - Jun 13 2013]

Entities: Prostate Cancer, Metastases, Prostate, Enzyme, Molecular Imaging Corp

First reported Jun 11 2013 - Updated Jun 12 2013 - 4 reports

Molecular Imaging Enlists Prostate Enzyme To Detect Metastases

Prostate-specific membrane antigen (PSMA) could become the hallmark of a new generation of biomarkers for both imaging and therapy of prostate cancerVancouver, British Columbia – No matter where they have hidden, metastatic prostate cancer cells still ... [Published Oncology Business Review - Jun 11 2013]

Entities: Prostate Cancer, Molecular Imaging Corp, Prostate, Metastases, Enzyme

First reported Jun 04 2013 - Updated Jun 04 2013 - 4 reports

Breast cancer New genetic test measures risk of metastases

Patients suffering from breast cancer in which the lymph nodes are already affected usually receive prophylactic chemotherapy which sometimes entails many side effects. Scientists at the Comprehensive Cancer Center Vienna CCC a joint establishment of ... [Published BioPortfolio - Jun 04 2013]

Entities: Metastases, Breast Cancer, Chemotherapy, Vienna

First reported May 31 2013 - Updated May 31 2013 - 2 reports

ESSO Advanced Course on the Surgical and Medical Management of Melanoma

This course aims at providing a detailed overview of the management of all types and stages of cutaneous melanoma, from diagnosis and primary treatment to the management of locoregional and distant metastases.The aim of this programme is to provide a ... [Published European Cancer Organisation - May 31 2013]

Entities: Skin Cancer, Metastases, Surgical Oncology, Surveillance

First reported May 30 2013 - Updated May 30 2013 - 2 reports

Oncothyreon Joins Array in Developing Cancer Compound

Oncothyreon will join Array BioPharma in developing its early clinical-stage small molecule HER2 inhibitor ARRY-380 by agreeing to fund proof-of-concept trials in patients with metastatic breast cancer (mBC), including patients with brain metastases.Oncothyreon ... [Published Genetic Engineering News - May 30 2013]

Entities: Oncothyreon Inc, Lapatinib, Breast Cancer

Quotes

...with non-small cell lung cancer who have developed the T790M resistance mutation," said Patrick J Mahaffy, President and CEO of Clovis Oncology. "We are extremely encouraged by these initial results which suggest that CO-1686 is well-tolerated and offers clear evidence of meaningful activity in a heavily pre-treated patient population, despite not yet having established our MTD. We look forward to continuing dose-escalation with our improved tablet formulation in our Phase I II trial, with the goal of identifying the dose to proceed into the expansion cohorts in our target patient populations and our registration studies."

Clovis Oncology announces encouraging results from Phase I lung cancer study [Published Individual.com - 1 hour ago]

"We are encouraged by the positive outcomes achieved with this particular patient sample," said Kevin Mosher, CEO of DFINE. "Until recently, these patients have had limited treatment options that provide rapid pain relief from spinal metastases and allow them tocontinue systemic therapy. With the STAR System, this is now a reality."

DFINE announces positive results from soft tissue sarcoma study [Published Individual.com - 1 hour ago]

...trial," stated Frank G Haluska, M D , Ph D , senior vice president of clinical research and development and chief medical officer at ARIAD. "In parallel to enrollment in the Phase 2 expansion cohorts, we plan to begin a pivotal trial of AP26113 in ALK-positive NSCLC patients who are resistant to crizotinib in the third quarter of 2013." Investor and Analyst Briefing and Webcast A breakfast meeting to review the most recent clinical data from the Phase 1 portion of the ongoing Phase 1/2...

ARIAD Presents Updated Phase 1 Data on AP26113 in Patients with Non-Small Cell Lung Cancer [Published Pharmacy Choice - Jun 19 2013]

"In time, it could also be formulated as a therapeutic radioactive drug."

Prostate Enzyme Enables Detection Of Metastases During Molecular Imaging [Published Health Imaging Hub - Jun 17 2013]

More Content

sort by: Date \| Relevance
Clovis Oncology announces encouraging results f... [Published Individual.com - 1 hour ago]
DFINE announces positive results from soft tiss... [Published Individual.com - 1 hour ago]
Biopsy-proven brain metastases from prostate ca... [Published UroToday - 15 hours ago]
ARIAD Presents Updated Phase 1 Data on AP26113 ... [Published Pharmacy Choice - Jun 19 2013]
FGFR1 Is Essential for Prostate Cancer Progress... [Published Bionity.com - Jun 19 2013]
Inhibition of c-Met Reduces Lymphatic Metastasi... [Published Bionity.com - Jun 19 2013]
Multidisciplinary Approach to Rectal Cancer: Ar... [Published Bionity.com - Jun 19 2013]
Some Squamous Cell Skin Cancers Are Deadly [Published CancerConnect.com - Jun 19 2013]
Cancer Pain Eased by MR-Guided, Focused Ultraso... [Published MedImaging.net - Jun 18 2013]
TURMERIC [Published Global FoodMate - Jun 18 2013]
Postmenopausal Hormone Receptor–Positive Advanc... [Published Cancernetwork.com - Jun 18 2013]
The Link Between Genes and Cancer [Published Health Canal - Jun 18 2013]
Prostate Enzyme Enables Detection Of Metastases... [Published Health Imaging Hub - Jun 17 2013]
Utility of semiquantitative parameters to diffe... [Published Clinical Imaging - Jun 17 2013]
Impact of anti-CD25 monoclonal antibody on dend... [Published 7thSpace - Jun 17 2013]
Groundbreaking Research in Radiation Oncology b... [Published Hospital Newspaper - Jun 17 2013]
A life that could be saved after all [Published British Medical Association - Jun 15 2013]
ASCO: Cetuximab Ups Survival Over Bevacizumab i... [Published Cancernetwork.com - Jun 14 2013]
Nurses ill at ease over palliative care changes [Published Central Western Daily - Jun 14 2013]
New Breast Cancer Findings from University of M... [Published NewsRX - Jun 14 2013]
Berkeley Lab researchers unlock mystery behind ... [Published NewsRX - Jun 14 2013]
Prostate enzyme may lead to better cancer imaging [Published Dotmed - Jun 14 2013]
EORTC BOS 2 trial opens for patients with resec... [Published NewsRX - Jun 14 2013]
Near A 52-Week Low, Is OncoGenex Pharmaceutical... [Published Seeking Alpha - Jun 13 2013]
Prostate Enzyme Abel to Detect Metastases durin... [Published Health Imaging Hub - Jun 13 2013]
As the First Biopharmaceutical Company Worldwid... [Published BioPortfolio - Jun 13 2013]
Northwest Bio: M.D. Anderson's Lead Role In DV ... [Published Seeking Alpha - Jun 13 2013]
Prostate Enzyme Enables Detection Of Metastases... [Published Big News Network - Jun 13 2013]
A PRESUMED MIRACLE [Published Sunday Catholic Weekly - Jun 12 2013]
Peregrine reports encouraging data from breast ... [Published Individual.com - Jun 12 2013]

Blogs

sort by: Date \| Relevance
Investment Research Weekly Roundup including: A... [Published Proactiveinvestors United Kingdom website - Jun 07 2013] Software Radio Technology - LON:SRT QuickView - Rising tide 06 June 2013 Software Radio Technology ’s (SRT) FY13 results show the company is returning to profitable growth. The business is much less vulnerable to the timing of individual orders ...
Crowdsourcing a Diagnosis With a Scientific Video [Published ScienceRoll - Jun 04 2013] László Rosta, PhD published a video in which he tries to find an explanation for the disease of a young boy by offering the video for crowdsourcing. He sent me this particular question: Do you have any therapeutic ideas which might be curative for inoperable ...
Stephen L. Coles is DYING and NEEDS your Help! [Published Lifeboat News The Blog - Jun 03 2013] * PLEASE alert your friends—Our own continued health and longevity may depend on Steve continuing his work.* This call for support was also posted by Ilia Stambler on the Longevity Alliance Website, and organized on YouCaring.com by John M. Adams. ...
Treating the patient, not the disease [Published db's Medical Rants - May 19 2013] The team presented his story during pre-rounds. He had lived his life “cleanly”, not smoking or drinking, eating in moderation. Recently he had a malignant disease present, and now had a new metastasis. As a physician, we want to like all patients, ...
Fight Aging! Newsletter, April 29th 2013 [Published Fight Aging! - Apr 28 2013] FIGHT AGING! NEWSLETTER April 29th 2013 The Fight Aging! Newsletter is a weekly email containing news, opinions, and happenings for people interested in aging science and engineered longevity: making use of diet, lifestyle choices, technology, and proven ...

Press Releases

sort by: Date \| Relevance
ARIAD Presents Updated Phase 1 Data on AP26113 ... [Published Business Wire Health News - Jun 02 2013]
Use Of Cryoablation For Treatment Of Breast Can... [Published PR Newswire: General Business - May 07 2013]
Study Demonstrates Significant Pain Reduction w... [Published Business Wire Health News - May 01 2013]
New Studies Show Clinically Significant Palliat... [Published Business Wire Health News - Apr 17 2013]
European Study Concludes Kiva® Effective in Tre... [Published PR Newswire: General Business - Mar 18 2013]